tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Neurotech Options Lapse, Streamlining Capital Structure

Story Highlights
  • Five million Neurotech options at $0.10 have expired unexercised on 23 December 2025.
  • The lapse trims Neurotech’s potential future equity dilution while leaving current share capital unchanged.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Neurotech Options Lapse, Streamlining Capital Structure

Claim 70% Off TipRanks Premium

Neurotech International ( (AU:NTI) ) has provided an update.

Neurotech International Limited has allowed 5 million unlisted options, exercisable at $0.10 and due to expire on 23 December 2025, to lapse without being exercised. The expiry of these options reduces the company’s pool of potential future equity issuance, slightly simplifying its capital structure but having no immediate impact on the number of ordinary shares on issue or existing shareholders’ current holdings.

More about Neurotech International

Average Trading Volume: 1,220,445

Technical Sentiment Signal: Sell

Current Market Cap: A$17.84M

See more data about NTI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1